(Q36771112)

16 August 2017

Combing signals from spontaneous reports and electronic health records for detection of adverse drug reactions (English)

1 reference

electronic health records

16 August 2017

1 reference

8

Carol Friedman

1 reference

16 August 2017

6

Nigam H Shah

1 reference

16 August 2017

Rave Harpaz

1

1 reference

16 August 2017

Santiago Vilar

2

1 reference

16 August 2017

William Dumouchel

3

1 reference

16 August 2017

Hojjat Salmasian

4

1 reference

16 August 2017

Krystl Haerian

5

1 reference

16 August 2017

Herbert S Chase

7

1 reference

16 August 2017

31 October 2012

1 reference

Journal of the American Medical Informatics Association

16 August 2017

1 reference

16 August 2017

20

1 reference

16 August 2017

3

1 reference

16 August 2017

413-419

1 reference

Annotation Analysis for Testing Drug Safety Signals using Unstructured Clinical Notes

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Using information mining of the medical literature to improve drug safety

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

A basic study design for expedited safety signal evaluation based on electronic healthcare data

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

A pharmacovigilance program from laboratory signals for the detection and reporting of serious adverse drug reactions in hospitalized patients.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Quantitative signal detection using spontaneous ADR reporting

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Decision support methods for the detection of adverse events in post-marketing data

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Early detection of adverse drug events within population-based health networks: application of sequential testing methods.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

The tell-tale heart: population-based surveillance reveals an association of rofecoxib and celecoxib with myocardial infarction

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Novel statistical tools for monitoring the safety of marketed drugs

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Data mining for signals in spontaneous reporting databases: proceed with caution

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

The role of data mining in pharmacovigilance

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Automated encoding of clinical documents based on natural language processing

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Disproportionality methods for pharmacovigilance in longitudinal observational databases

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Methemoglobinemia and hemolytic anemia after rasburicase administration in a child with leukemia.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicities

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Rhabdomyolysis and Myoglobinuria

5 September 2018

1 reference

12 December 2020

Predicting adverse drug events using pharmacological network models

1 reference

12 December 2020

Drug safety reform at the FDA--pendulum swing or systematic improvement?

1 reference

12 December 2020

Managing drug-risk information--what to do with all those new numbers

1 reference

12 December 2020

The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France

1 reference

12 December 2020

What can we really learn from observational studies?: the need for empirical assessment of methodology for active drug safety surveillance and comparative effectiveness research

1 reference

12 December 2020

The New Sentinel Network — Improving the Evidence of Medical-Product Safety

1 reference

12 December 2020

An evaluation of computer-aided disproportionality analysis for post-marketing signal detection

1 reference

12 December 2020

1 reference

12 December 2020

Diagnosis and management of acute pancreatitis

1 reference

12 December 2020

10.1136/AMIAJNL-2012-000930

Identifiers

DOI

1 reference

journals/jamia/HarpazVDSHSCF13

16 August 2017

1 reference

DBLP Dataset 2021-01-02

28 January 2021

1 reference

16 August 2017

PubMed publication ID

23118093

1 reference